Hormonal regulation of hippocampal spine synapse density involves subcortical mediation.
It is well established that estrogen has positive effects on the density of pyramidal cell spines in the hippocampal CA1 subfield. This study explored whether afferent connections of the hippocampus that come from estrogen-sensitive subcortical structures, including the septal complex, median raphe and supramammillary area, play a role in this estrogen-induced hippocampal synaptic plasticity. These particular subcortical structures have major influences on hippocampal activity, including theta rhythm and long-term potentiation. The latter also promotes the formation of new synapses. All of the rats were ovariectomized; the fimbria/fornix, which contains the majority of subcortical efferents to the hippocampus, was transected unilaterally in each, and half of the animals received estrogen replacement. Using unbiased electron microscopic stereological methods, the CA1 pyramidal cell spine synapse density was calculated. In the estrogen-treated rats, contralateral to the fimbria/fornix transection, the spine density of CA1 pyramidal cells increased dramatically, compared to the spine density values of both the ipsilateral and contralateral hippocampi of non-estrogen-treated animals and to that of the ipsilateral hippocampus of the estrogen replaced rats. These observations indicate that fimbria/fornix transection itself does not considerably influence CA1 area pyramidal cell spine density and, most importantly, that the estrogenic effect on hippocampal morphology, in addition to directly affecting the hippocampus, involves subcortical mediation.
Leranth
C
C
Department of Obstetrics and Gynecology, Yale University, School of Medicine, 333 Cedar Street, FMB 328, New Haven, CT 06520-8063, USA. csaba.leranth@yale.edu
Shanabrough
M
M
Horvath
T L
TL
D000344:Afferent Pathways / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D000818:Animals; D001369:Axons / Q000378:metabolism / Q000648:ultrastructure; D003712:Dendrites / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D003714:Denervation / Q000009:adverse effects; D004967:Estrogens / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D020712:Fornix, Brain / Q000601:surgery; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D007031:Hypothalamus / Q000166:cytology / Q000378:metabolism / Q000601:surgery; D017966:Pyramidal Cells / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D011903:Raphe Nuclei / Q000166:cytology / Q000378:metabolism / Q000601:surgery; D051381:Rats; D017207:Rats, Sprague-Dawley; D012686:Septal Nuclei / Q000166:cytology / Q000378:metabolism / Q000601:surgery; D012701:Serotonin / Q000378:metabolism; D013569:Synapses / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*
D004967:Estrogens; D012701:Serotonin